Evidence map›Paper›PMID 11306554›Full record

ArticleEMBO reports2001

Stoichiometry and kinetics of transport vesicle fusion with Golgi membranes.

J Ostermann

Abstract read
In one paragraph

Article in EMBO reports, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

J OstermannEuropean Molecular Biology Laboratory, Cell Biology Program, Meyerhofstrasse 1, 69117 Heidelberg, Germany. Joachim.Ostermann@embl-heidelberg.de

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The in vitro complementation assay established by Rothman and co-workers continues to be an important tool to study intra-Golgi transport. In this study, kinetic modeling is used to identify four main parameters that, together, explain the basic features of an assay that is a modification of the original assay. First, the assay signal depends on the ratio of Golgi membranes to transport intermediates in the assay. Secondly, an inactivation rate describes how the activity of transport intermediates decreases over time. Thirdly, the rate at which transport intermediates irreversibly bind to Golgi membranes is measured independently of membrane fusion, thus allowing a quantitative distinction between these two steps. Fourthly, a single rate constant describes the remaining reactions, which result in membrane fusion. This approach of kinetic modeling of experiments is generally applicable to other in vitro assays of cell biological phenomena, permitting quantitative interpretations and an increased resolution of the experiments.

Indexed as

Arabidopsis ProteinsMembrane GlycoproteinsPlant ProteinsAnimalsCCAAT-Enhancer-Binding ProteinsCHO CellsCricetinaeDose-Response Relationship, DrugEgtazic AcidGlycosylationGolgi ApparatusHexosaminidasesIntracellular MembranesKineticsLiverModels, Biological1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidArabidopsis ProteinsCCAAT-Enhancer-Binding ProteinsEgtazic AcidG protein, vesicular stomatitis virusHexosaminidasesLEC1 protein, ArabidopsisMembrane GlycoproteinsPlant ProteinsTranscription FactorsUridine Diphosphate N-AcetylglucosamineViral Envelope Proteins

Identifiers

PMID11306554
PMCPMC1083864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.